Skip to main content
Funded Studies

Veerle Baekelandt, PhD

Full Professor at KU Leuven

Location: Leuven Belgium

Veerle Baekelandt obtained a master’s degree in romance languages (1987) and a Master (1991) and PhD in biology (1995) at the KU Leuven, Belgium. In 1992, she received a Frank Boas Fulbright scholarship for graduate study at Harvard University and became a research fellow in the laboratory for Neuroscience Research, Children’s Hospital, Harvard Medical School, Boston (1992-1993). In 1999, she joined a new gene therapy project for neurodegenerative diseases in Leuven. In 2003 she was appointed as assistant professor at the faculty of medicine at the KU Leuven and in 2007 as full-time research professor. She is now head of the Laboratory for Neurobiology and Gene Therapy ( Her research focuses on disease modeling and therapy for Parkinson’s disease and related synucleinopathies, with alpha-synuclein and LRRK2 as main interests. Core technologies of the group consist of viral vector technology, stereotactic neurosurgery and molecular imaging in rats and mice.

Associated Grants

  • Inhibiting Programmed Cell Death to Reduce Axonal Degeneration and Brain Inflammation in Parkinson's Disease


  • IMPACT-PD - Implications of Polyamine and Glucosylceramide Transport in Parkinson’s Disease


  • Study of the Molecular and Cellular Consequences of LRRK2 Kinase Inhibition in Neurons and Microglia


  • Is ATP13A2 a Lysosomal Lipid Flippase that Affects Alpha-synuclein Membrane Interactions?


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.